Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +56.03%
#3 Glidr Glidr +38.25%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.97%
#6 Humanity Humanity +20.80%
#7 Tutorial Tutorial +17.00%
#8 Enso Enso +15.98%
#9 Velvet Velvet +15.00%
#10 Huma Finance Huma Finance +13.59%
Coin of the day
EXOD EXOD
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Classifica tra le azioni #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Prezzo delle azioni
$0.069
Ultima sincronizzazione: 2024-07-22
Capitalizzazione di mercato
$2.06M
Variazione (1 giorno)
-1.43%
Variazione (1 anno)
0.00%
Paese
US
Scambia DermTech, Inc. (DMTK)

Categoria

Healthcare
EPS per DermTech, Inc. (DMTK)
EPS al March 2024 TTM: $-2.70
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di DermTech, Inc., l’EPS attuale della società (TTM) è $-2.70. Alla fine del 2022, la società aveva un EPS di $-3.88 un aumento rispetto a rispetto a quello del 2021, che era di $-2.71.
Storico EPS per DermTech, Inc. da 2012 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-2.70 -12.62%
2023 $-3.09 -20.36%
2022 $-3.88 43.17%
2021 $-2.71 32.20%
2020 $-2.05 -34.50%
2019 $-3.13 -969.44%
2018 $0.36 0.00%
2017 0.00 -100.00%
2013 $-1.10 69.23%
2012 $-0.65 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $18.62 -789.63%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $5.65 -309.26%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $-1.36 -49.63%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $14.24 -627.41%
US